|
2024
|
Invention
|
Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy.
An immunomodulato... |
|
2023
|
Invention
|
Immunogenic treatment of cancer.
The present invention provides an immunomodulator for use in th... |
|
2021
|
Invention
|
A mycobacterium for use in cancer therapy. This invention provides an immunomodulator for use in ... |
|
|
Invention
|
Mycobacterial immunotherapy for treating cancer.
This invention provides an immunomodulator for ... |
|
|
Invention
|
Mycobacterial immunotherapy for treating cancer. This invention provides an immunomodulator for u... |
|
|
Invention
|
A mycobacterium for use in cancer therapy.
This invention provides an immunomodulator for use in... |
|
|
Invention
|
A mycobacterium for use in cancer therapy. MycobacteriumMycobacterium. The invention also describ... |
|
|
Invention
|
Mycobacterium for use in cancer therapy. M. obuense. |
|
|
Invention
|
Prevention and treatment of infections including those caused by coronavirus.
The present invent... |
|
|
Invention
|
Prevention and treatment of infections including those caused by coronavirus. Mycobacterium Mycob... |
|
2020
|
Invention
|
Immunotherapeutic treatment of cancer.
The present invention relates to the field of cancer ther... |
|
|
Invention
|
Immunotherapeutic treatment of cancer. The present invention relates to the field of cancer thera... |
|
|
Invention
|
Immunogenic treatment of cancer. The present invention provides an immunomodulator for use in the... |
|
|
Invention
|
Immunotherapeutic agent.
Compounds for use in the treatment of sepsis and/or the prevention or t... |
|
2019
|
Invention
|
Cancer therapy.
A non-viable, whole-cell Mycobacterium for use in the treatment, reduction, inhi... |
|
|
Invention
|
Cancer therapy. A non-viable, whole-cell Mycobacterium for use in the treatment, reduction, inhib... |
|
|
Invention
|
Cancer therapy. MycobacteriumMycobacteriumMycobacterium, and/or co-stimulatory checkpoint therapy... |
|
|
P/S
|
Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system r... |
|
|
Invention
|
Immunotherapeutic agent. Compounds for use in the treatment of sepsis and/or the prevention or tr... |
|
2018
|
P/S
|
Pharmaceutical and medicinal preparations and substances;
dietetic substances adapted for medica... |
|
|
Invention
|
Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy. M. obuense. |
|
|
P/S
|
Pharmaceutical and medicinal preparations and substances; dietetic substances adapted for medical... |
|
2017
|
Invention
|
Immunotherapeutic treatment of cancer. The present invention resides in the preparation of a medi... |
|
2016
|
Invention
|
A method for producing macrophages by incubating monocytes with non-viable mycobacterium. A metho... |
|
|
Invention
|
A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy. An immunomodulat... |
|
2014
|
Invention
|
Cancer therapy.
The present invention resides in the preparation of a medicament to aid in the t... |
|
2013
|
Invention
|
Mycobacterium. Mycobacterium. |
|
|
Invention
|
Treatment of post-traumatic stress disorder with isolated mycobacterium. The present invention re... |
|
2012
|
Invention
|
Cancer therapy. The present invention relates to a method of preventing, treating or inhibiting t... |
|
2011
|
Invention
|
Method of producing rough strains of bacteria and uses thereof. Mycobacterium obuense deposited u... |
|
2006
|
Invention
|
Method of producing rough strains of mycobacterium bacteria and uses thereof. The present i... |
